We are live on ! Find out more
Adage Capital Partners

Adage Capital Partners Portfolio holdings

AUM $64.8B
1-Year Est. Return 42.7%
This Fund
S&P 500
This Quarter Est. Return
+1.53%
1 Year Est. Return
+42.7%
3 Year Est. Return
+139.29%
5 Year Est. Return
+204.38%
10 Year Est. Return
+829.83%
AUM
$64.8B
AUM Growth
-$1.23B
Cap. Flow
+$395M
Cap. Flow %
0.61%
Top 10 Hldgs %
28.4%
Holding
1,116
New
212
Increased
277
Reduced
389
Closed
160

Top Sells

Rank Stock Value
1
RNAM
Avidity Biosciences
RNAM
+$190M
2
RPRX icon
Royalty Pharma
RPRX
+$187M
3
DOV icon
Dover
DOV
+$178M
4
BA icon
Boeing
BA
+$168M
5
DVN icon
Devon Energy
DVN
+$155M

Sector Composition

Rank Sector Weight
1 Technology 27.24%
2 Healthcare 15.45%
3 Financials 12.46%
4 Industrials 9.23%
5 Communication Services 8.79%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ANNX icon
426
Annexon
ANNX
$855M
$23.8M 0.04%
4,300,000
-1,200,000
-22% -$6.76M
CABA icon
427
Cabaletta Bio
CABA
$439M
$23.8M 0.04%
8,829,758
BETA
428
Beta Technologies Inc
BETA
$4.2B
$23.3M 0.04%
1,583,594
+812,905
+105% +$16.7M
CNP icon
429
CenterPoint Energy
CNP
$29.1B
$23.2M 0.04%
537,838
-51,600
-9% -$2.13M
EIX icon
430
Edison International
EIX
$30.7B
$23.2M 0.04%
316,704
-30,700
-9% -$2.07M
WTRG icon
431
Essential Utilities
WTRG
$11.2B
$22.9M 0.04%
+567,799
New +$22.3M
PCAR icon
432
PACCAR
PCAR
$69.6B
$22.9M 0.04%
197,950
-451,248
-70% -$54.6M
FICO icon
433
Fair Isaac
FICO
$28.7B
$22.6M 0.03%
21,200
-200
-0.9% -$274K
MCHP icon
434
Microchip Technology
MCHP
$42.8B
$22.6M 0.03%
+349,785
New +$25.2M
BNTC icon
435
Benitec Biopharma
BNTC
$394M
$22.6M 0.03%
2,120,672
FVAV
436
Fortress Value Acquisition Corp V
FVAV
$22.6M 0.03%
+2,250,000
New +$22.6M
BBCQ
437
Bleichroeder Acquisition Corp II
BBCQ
$393M
$22.5M 0.03%
+2,250,000
New +$22.5M
ACAAU
438
Averin Capital Acquisition Corp Units
ACAAU
$22.5M 0.03%
+2,250,000
New +$22.6M
IEAG
439
Infinite Eagle Acquisition Corp
IEAG
$22.5M 0.03%
+2,250,000
New +$22.5M
OIM
440
OneIM Acquisition Corp
OIM
$364M
$22.4M 0.03%
+2,250,000
New +$22.5M
APXT
441
Apex Treasury Corp
APXT
$466M
$22.4M 0.03%
2,250,000
ALGN icon
442
Align Technology
ALGN
$12B
$22.3M 0.03%
130,314
+81,114
+165% +$14.2M
OCS icon
443
Oculis Holding
OCS
$672M
$22.2M 0.03%
+833,209
New +$22.1M
SBRA icon
444
Sabra Healthcare REIT
SBRA
$5.64B
$22.1M 0.03%
1,150,000
-35,000
-3% -$689K
CWAN
445
DELISTED
Clearwater Analytics
CWAN
$22.1M 0.03%
+935,000
New +$22.1M
KOD icon
446
Kodiak Sciences
KOD
$2.59B
$21.9M 0.03%
575,000
-210,000
-27% -$5.43M
DCOM icon
447
Dime Commercial Bancshares
DCOM
$1.75B
$21.8M 0.03%
645,080
+202,361
+46% +$6.65M
SAFT icon
448
Safety Insurance
SAFT
$1.52B
$21.8M 0.03%
300,000
DFTX
449
Definium Therapeutics
DFTX
$5.73B
$21.7M 0.03%
1,150,000
HSY icon
450
Hershey
HSY
$35.4B
$21.6M 0.03%
103,785
+1,000
+1% +$211K

Similar funds

Adage Capital Partners's Q1 2026 Portfolio in Review

As of Q1 2026, Adage Capital Partners held 1,116 positions worth $64.8B, down 1.9% from $66.1B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Adage Capital Partners's Q1 2026 filing shows 212 new, 277 increased, 389 reduced and 160 closed positions. Its largest new stake was Takeda Pharmaceutical: 6,424,984 shares worth $119M. The largest sale was Avidity Biosciences, an estimated $190M.

By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 29% a quarter earlier, followed by Healthcare and Financials.

  • Adage Capital Partners's largest Q1 2026 buy was Takeda Pharmaceutical: 6,424,984 shares worth $119M.
  • Adage Capital Partners added most to Revolution Medicines in Q1 2026, an estimated $330M increase.
  • Adage Capital Partners's biggest Q1 2026 reduction was Royalty Pharma, cutting an estimated $187M.
  • Adage Capital Partners fully exited Avidity Biosciences in Q1 2026, selling an estimated $190M.
  • Adage Capital Partners's ten largest holdings make up 28% of its $64.8B portfolio in Q1 2026.
  • Adage Capital Partners opened 212 new positions and closed 160 in Q1 2026.
  • Adage Capital Partners's portfolio value fell 1.9% quarter-over-quarter to $64.8B.

Based on Adage Capital Partners's 13F filing for Q1 2026, filed 15 May 2026.